Anaptysbio (ANAB) Share-based Compensation (2021 - 2026)
Anaptysbio's Share-based Compensation came in at $14.22 million for Q1 2026, up 55.0% from $9.17 million a year earlier and up 67.2% from the prior quarter.
Anaptysbio (ANAB) Share-based Compensation (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Anaptysbio reported Share-based Compensation of $41.12 million, up 24.3% year-over-year; for FY2025, it was $36.07 million, up 5.9% from FY2024.
- Share-based Compensation has increased in each of the last four years, with a four-year compound annual growth rate of 23.8% (FY2021 to FY2025).
- Going back by year, Share-based Compensation was $34.05 million in FY2024 (+2.5%), $33.21 million in FY2023 (+21.4%), $27.36 million in FY2022 (+78.2%) and $15.35 million in FY2021.
- The Q1 2026 figure represents the highest quarterly Share-based Compensation in data going back to Q1 2021.
- Year-over-year, Share-based Compensation has increased for four consecutive quarters, with growth averaging 9.9% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2022 (growth of 133.5%), and the weakest in Q2 2024 (a decline of 10.5%).
- Business Quant data shows ANAB's Share-based Compensation at $8.51 million (Q4 2025), $9.16 million (Q3 2025) and $9.24 million (Q2 2025) in the three quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Anaptysbio | 1.47 Bn | 362.02 Mn | - | 14.22 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 14.22 Mn |
| Dec 31, 2025 | 8.51 Mn |
| Sep 30, 2025 | 9.16 Mn |
| Jun 30, 2025 | 9.24 Mn |
| Mar 31, 2025 | 9.17 Mn |
| Dec 31, 2024 | 8.18 Mn |
| Sep 30, 2024 | 8.19 Mn |
| Jun 30, 2024 | 7.54 Mn |
| Mar 31, 2024 | 10.13 Mn |
| Dec 31, 2023 | 8.11 Mn |
| Sep 30, 2023 | 7.81 Mn |
| Jun 30, 2023 | 8.43 Mn |
| Mar 31, 2023 | 8.86 Mn |
| Dec 31, 2022 | 6.69 Mn |
| Sep 30, 2022 | 6.27 Mn |
| Jun 30, 2022 | 6.66 Mn |
| Mar 31, 2022 | 7.74 Mn |
| Dec 31, 2021 | 3.98 Mn |
| Sep 30, 2021 | 4.36 Mn |
| Jun 30, 2021 | 3.69 Mn |
Anaptysbio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();